Zobrazeno 1 - 10
of 82
pro vyhledávání: '"Gülersu Irken"'
Autor:
Özlem Tüfekçi, Şebnem Yılmaz Bengoa, Fatma Demir Yenigürbüz, Erdem Şimşek, Tuba Hilkay Karapınar, Gülersu İrken, Hale Ören
Publikováno v:
Turkish Journal of Hematology, Vol 32, Iss 4, Pp 329-337 (2015)
INTRODUCTION: Rapid and effective treatment of invasive fungal infection (IFI) in patients with leukemia is important for survival. In this study, we aimed to describe variations regarding clinical features, treatment modalities, time of restarting c
Externí odkaz:
https://doaj.org/article/32407febcd6646409c1b34f0e52abee8
Autor:
Özlem Tüfekçi, Hale Ören, Fatma Demir Yenigürbüz, Salih Gözmen, Tuba Hilkay Karapınar, Gülersu İrken
Publikováno v:
Turkish Journal of Hematology, Vol 32, Iss 2, Pp 175-179 (2015)
Juvenile myelomonocytic leukemia (JMML) is a rare clonal myeloproliferative disorder of childhood. Major progress has been achieved in diagnosis and the understanding of the pathogenesis of JMML by identifying the genetic pathologies that occur in pa
Externí odkaz:
https://doaj.org/article/a34836102efe426db17c92b14a94fb6b
Autor:
Hale Ören, Şebnem Yılmaz, Özlem Tüfekçi, Mustafa Kır, Ece Böber, Gülersu İrken, Pakize Karakaya
Publikováno v:
Turkish Journal of Hematology, Vol 30, Iss 3, Pp 290-299 (2013)
Objective: Survival rates for childhood acute lymphoblastic leukemia (ALL) have significantly improved and late effects of therapy have been important in the follow-up of survivors. The objective of this study is to identify the endocrinological and
Externí odkaz:
https://doaj.org/article/b024abcfce6c45f2b5294fb0cf7995db
Autor:
Fatih Demircioğlu, Şule Çağlayan Sözmen, Şebnem Yılmaz, Hale Ören, Nur Arslan, Abdullah Kumral, Erdener Özer, Gülersu İrken
Publikováno v:
Turkish Journal of Hematology, Vol 27, Iss 3, Pp 204-208 (2010)
A 33 weeks' gestation, a baby with rhesus hemolytic disease (RHD), who had received intrauterine transfusions twice, developed cholestatic hepatic disease and late hyporegenerative anemia. Her serum ferritin and bilirubin levels increased to 8842 ng/
Externí odkaz:
https://doaj.org/article/8a215f27752748b49f89c8ce3ebac92e
Autor:
Tuba Hilkay Karapınar, Salih Gözmen, Özlem Tüfekçi, Şebnem Yılmaz, Zeynep Özbek, Melih Parlak, Gülersu İrken, Hale Ören
Publikováno v:
Turkish Journal of Hematology, Vol 29, Iss 1, Pp 85-86 (2012)
Externí odkaz:
https://doaj.org/article/07d711434db04f3f861e6a1b9a1a74d6
Autor:
Hale Ören, Özlem Tüfekçi, Meral Türker, Salih Gözmen, Gülersu Irken, Berna Atabay, Şebnem Yılmaz Bengoa, Tuba Hilkay Karapınar
Publikováno v:
Journal of Pediatric Hematology/Oncology. 39:440-444
The increased awareness about the severity of complications in thalassemia intermedia patients led authorities to develop strategies for better management and follow-up of these patients. In this study, we aimed to define the clinical and laboratory
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ee20352f458a6731bbe1641149d7412
https://doi.org/10.1097/mph.0000000000000914
https://doi.org/10.1097/mph.0000000000000914
Autor:
Diyar Z. Akkaynak, Yeşim Oymak, Gonul Aydogan, Tuğba Gürleyen Eren, Gülsün Karasu, Bahattin Tunç, Fatma Gumruk, Selma Unal, Umran Caliskan, Turkan Patiroglu, Adalet Meral Güneş, Zafer Salcioglu, Ahmet Koç, Yusuf Ziya Aral, Yasemin Isik Balci, Mehmet Akin, Aylin Canbolat Ayhan, Vedat Uygun, Osman Alphan Küpesiz, Gönül Oktay, Canan Vergin, Betül Biner, İlgen Şaşmaz, Mehmet Ertem, Hilmi Apak, Emine Türkkan, Yıldız Yildirmak, Cetin Timur, Elif Güler Kazanci, Gülersu Irken, Ülker Koçak, Murat Söker, Erdal Kurtoğlu, Mehmet Akif Yesilipek, Bülent Antmen, Zeynep Karakas
PubMedID: 30300449 Objectives: To evaluate the long-term efficacy and safety of deferasirox therapy in a large observational cohort of children with transfusion-dependent thalassemia (TDT) and sickle cell anemia (SCA) in Turkey. Methods: This was a m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b5a731b446ddb4e25ef6dbad909d7cf
Autor:
Melike Sezgin Evim, Hale Ören, Tuba Hilkay Karapınar, Adalet Meral Güneş, Salih Gözmen, Şebnem Yılmaz Bengoa, Özlem Tüfekçi, Gülersu Irken, Birol Baytan
Publikováno v:
Annals of Hematology. 93:1677-1684
Dramatic progress in the treatment of childhood acute lymphoblastic leukemia (ALL) has been achieved during the last two decades in Western countries, where the 5-year event-free survival (EFS) rate has risen from 30 to 85 %. However, similarly high
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9588b4fe75f1a6c4dee42086dbea4e9
https://doi.org/10.1007/s00277-014-2106-0
https://doi.org/10.1007/s00277-014-2106-0
Autor:
Mustafa Kir, Hale Ören, Pakize Karakaya, Şebnem Yılmaz, Gülersu Irken, Özlem Tüfekçi, Ece Böber
Publikováno v:
Turkish Journal of Hematology, Vol 30, Iss 3, Pp 290-299 (2013)
Turkish Journal of Hematology
Turkish Journal of Hematology
Objective: Survival rates for childhood acute lymphoblastic leukemia (ALL) have significantly improved and late effects of therapy have been important in the follow-up of survivors. The objective of this study is to identify the endocrinological and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8ed9aad5546910d26a264eb5d7c0e6f
https://doaj.org/article/b024abcfce6c45f2b5294fb0cf7995db
https://doaj.org/article/b024abcfce6c45f2b5294fb0cf7995db
Autor:
Hale Ören, Faize Yuksel, Salih Gözmen, Gülersu Irken, Canan Vergin, Özlem Tüfekçi, Aydan Çankal
Publikováno v:
Blood Coagulation & Fibrinolysis. 24:375-380
The objective of this study was to evaluate the protein Z levels of children with acute lymphoblastic leukaemia (ALL) during induction therapy. Although several studies investigated the association between steroid and L-asparaginase (L-ASP) administr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b8152da7096dccf80cc9607c017d4f6
https://doi.org/10.1097/mbc.0b013e32835d06f1
https://doi.org/10.1097/mbc.0b013e32835d06f1